Menu

StockMarket

Jio’s Giant Leap: Reliance Confirms IPO in Early 2026

Reliance Power Share Price Jumps 7% Amidst Flat Stock Market

Reliance Power Share Price Jumps 7% Amidst Flat Stock Market

 

Reliance Power’s stock demonstrated remarkable strength, soaring by 7% in an otherwise stagnant Indian stock market. This notable upward movement underscores the specific positive drivers influencing the stock, setting it apart from the general market trend.

Exceptional Returns and Multibagger Performance Attract Investors

The company’s history of delivering exceptional returns has likely played a significant role in attracting investor interest. The staggering 294% appreciation in the stock’s value over the past two years, coupled with an even more impressive 2,031% gain over the last five years, firmly establishes Reliance Power as a multibagger. Such substantial returns often draw attention from both retail and institutional investors seeking high-growth opportunities.

Intraday Trading Dynamics and Investor Confidence

The early trading session on April 24, 2025, witnessed a robust rally, with the stock price climbing as much as 7.62% to reach ₹46.87 on the BSE. This early surge reflects strong initial buying pressure and a positive market sentiment specifically surrounding Reliance Power. It suggests that investors were keen to accumulate the stock from the opening bell, indicating confidence in its near-term prospects.

Surge in Trading Volumes Signals Heightened Interest

The significant gains in Reliance Power’s share price were accompanied by a substantial increase in trading volumes on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). The exchange of approximately 6 crore Reliance Power shares surpassed its one-week average trading volume of 5 crore shares. This heightened activity is a strong indicator of increased investor participation and conviction in the stock’s upward trajectory.

Positive Momentum in the Power Sector

While the broader market lacked clear direction, the BSE Power index exhibited a positive bias, gaining 0.28%. This sectoral strength, fueled by advances in other prominent power sector players such as Tata Power, Suzlon Energy, Adani Green Energy, NTPC, Siemens, JSW Energy, and Adani Power, may have indirectly contributed to the positive sentiment surrounding Reliance Power. Investors often view companies within the same sector favorably when the overall sector shows positive momentum.

Market Decoupling Amidst Broader Weakness

The rally in Reliance Power’s share price occurred in contrast to the overall Indian stock market, which experienced a downturn, ending its seven-day winning streak. The benchmark Sensex declined by 315.06 points (0.39%) to close at 79,801.43, and the Nifty 50 fell by 82.25 points (0.34%) to settle at 24,246.70. This divergence highlights the specific positive catalysts driving Reliance Power, enabling it to outperform the general market trend.

Technical Analyst’s Perspective: Hold Existing Positions

According to Ruchit Jain, Vice President, Equity Technical Research at Motilal Oswal Financial Services Ltd, Reliance Power’s stock is currently trading within a defined range. The stock faces resistance around its previous swing high of ₹48 – ₹49, recorded in December, while it has established support at the ₹41 level. Jain advises traders holding existing positions at lower levels to maintain their stance. However, he does not recommend initiating fresh buy positions at the current juncture, anticipating a period of sideways trading for the stock.

Consistent Recent Gains Bolster Investor Sentiment

Reliance Power’s stock has demonstrated a consistent upward trend in recent times, recording a 22% gain over the past month and an impressive over 20% increase in the last three months. Looking at the year-to-date performance, the stock is up by 4%, and over the past year, it has surged by a remarkable 68%. This sustained positive performance likely reinforces investor confidence and attracts further buying interest.

Exceptional Long-Term Value Creation

The long-term returns generated by Reliance Power’s stock are truly exceptional. The 294% appreciation over two years and the staggering 2,031% return over five years underscore its status as a significant wealth creator for long-term investors. This track record of high returns often makes the stock attractive to investors with a longer investment horizon.

Current Market Standing

As of 9:35 AM on April 24, 2025, Reliance Power’s share price was trading at ₹46.20 apiece on the BSE, marking a significant 6.08% increase for the day.

Important Disclaimer for Investors

It is crucial to remember that the views and recommendations expressed are those of individual analysts or broking companies and do not represent the opinion of Mint. Investors are strongly advised to consult with certified financial experts before making any investment decisions to ensure they align with their individual risk tolerance and financial goals.

 

 

 

 

 

 

The image added is for representation purposes only

Lupin Soars on USFDA Nod for Billion-Dollar Drug

Lupin Soars on USFDA Nod for Billion-Dollar Drug

Lupin Soars on USFDA Nod for Billion-Dollar Drug

Lupin Soars on USFDA Nod for Billion-Dollar Drug

 

 

Exclusive 180-day window fuels stock jump after Tolvaptan approval for kidney disease treatment.

Shares of the Mumbai-based pharmaceutical giant, Lupin Limited, experienced a significant surge, climbing nearly 3% on Thursday, April 24th. This positive market reaction followed the announcement that the company had secured a crucial approval from The USFDA granted approval for Lupin’s New Drug Application concerning Tolvaptan tablets, available in strengths of 15mg, 30mg, 45mg, 60mg, and 90mg.

Exclusive Opportunity in a Lucrative Market

This regulatory clearance is particularly significant for Lupin as it marks their position as the first generic manufacturer to receive approval for this specific drug. This “first-to-file” status grants Lupin a valuable 180-day period of exclusive marketing rights for generic Tolvaptan in the United States. Industry analysts anticipate that Lupin will effectively be the sole generic supplier of this medication for a substantial portion of the financial year 2026, providing a considerable competitive advantage.

Substantial Revenue Projections

Financial experts have already begun to assess the potential financial impact of this approval on Lupin’s performance. Preliminary projections indicate that Lupin may earn $150 million to $200 million this fiscal year from the launch of generic Tolvaptan. This influx of revenue is poised to significantly bolster the company’s financial results.

Strategic Manufacturing and Swift Market Entry

Lupin has announced that its Tolvaptan tablets will be produced at their state-of-the-art pharmaceutical facility in Nagpur, India. The company has also indicated its intention to expedite the launch of the product in the US market, aiming to capitalize on the 180-day exclusivity period as quickly as possible.

Bioequivalence to a Key Branded Drug

The approved Tolvaptan tablet developed by Lupin is a bioequivalent version of Jynarque tablets, which are marketed by Otsuka Pharmaceutical Company. Bioequivalence signifies that Lupin’s generic version is designed to have the same therapeutic effect as the original branded drug, ensuring patients have access to a comparable treatment option.

Addressing a Critical Medical Need

Tolvaptan is indicated for use in adult patients who are at risk of experiencing a rapid decline in kidney function due to autosomal dominant polycystic kidney disease (ADPKD). The development of many kidney cysts is a hallmark of ADPKD, a hereditary condition that can ultimately result in renal failure. Tolvaptan plays a crucial role in slowing down this progression, offering a vital treatment option for affected individuals.

A Significant Market Opportunity

In the US, there is a sizable market for tolvaptan. According to data from December 31, 2024, the estimated annual sales of Tolvaptan in the US reached an impressive $1.467 billion. This figure underscores the significant commercial potential that Lupin can now tap into with its generic version.

Boosting Earnings and Offsetting Losses

Analysts predict that the introduction of generic Tolvaptan (Tolvaptan) could contribute over 25% to Lupin’s overall earnings in the current fiscal year. Additionally, in the fiscal year 2026, it is anticipated to be the main factor driving the drugmaker’s financial success. This new product launch is also strategically important as it will help to counterbalance any potential revenue decline anticipated from the generic version of Mirabegron (gMirabegron) in FY26.

Revised Financial Outlook

Following this significant USFDA approval, financial institutions are revising their forecasts for Lupin. Axis Capital, for instance, has adjusted its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) and Profit After Tax (PAT) estimates for Lupin in FY26 upwards by 8% and 10%, respectively. These revisions directly reflect the anticipated positive impact of the tolvaptan launch on the company’s profitability.

Market Reaction and Investor Confidence

The positive market response was evident in the nearly 3% gain in Lupin’s share price on the day of the announcement. The stock reached an intraday high of ₹2149.5 apiece, demonstrating strong investor confidence in the company’s prospects following this regulatory success. Even after some fluctuation, the stock continued to trade significantly higher, indicating sustained positive sentiment.

Final Thoughts

Lupin’s recent USFDA approval for its generic Tolvaptan tablets marks a significant milestone for the company. Securing the first-to-file status and the accompanying 180-day exclusivity period positions Lupin for substantial revenue generation in a nearly $1.5 billion market. Analysts foresee this launch as a major catalyst for the company’s earnings growth in the coming fiscal years, effectively offsetting anticipated losses from other generic products. The market’s positive reaction, with a notable surge in Lupin’s share price, underscores the significance of this regulatory achievement and its potential to drive the company’s future financial performance. This strategic win not only strengthens Lupin’s presence in the US generic market but also highlights its capabilities in navigating the complex regulatory landscape and bringing crucial medications to patients.

 

 

 

 

 

 

The image added is for representation purposes only

Analysts Weigh In: KFin Technologies’ Ascent Acquisition Could Drive Future Growth

Tata Power Rises 4% on ₹4,500 Crore Deal with NTPC!

Tata Power Rises 4% on ₹4,500 Crore Deal with NTPC!

Tata Power Rises 4% on ₹4,500 Crore Deal with NTPC!

Tata Power Renewable Energy’s 200 MW agreement with NTPC boosts investor confidence and aligns with India’s clean energy vision.

Tata Power jumps after NTPC deal.

Mumbai, India – Tata Power shares rallied nearly 4% in early trade after its renewable energy subsidiary, Tata Power Renewable Energy Limited (TPREL), clinched a massive Rs 4,500 crore order from NTPC. The deal, confirmed through a regulatory filing on Tuesday, involves a 25-year Power Purchase Agreement (PPA) with NTPC Vidyut Vyapar Nigam Ltd (NVVNL), a wholly owned subsidiary of NTPC Limited. The agreement is for the supply of 200 MW of firm and dispatchable renewable energy, a significant step forward in India’s clean energy mission.

A Major Win in India’s Green Transition

This contract marks a crucial milestone in TPREL’s journey, underscoring its leadership in the renewable space and aligning perfectly with India’s ambitious goal of reaching a capacity of 500 gigawatts (GW) from non-fossil fuel sources by 2030. The project entails integrating solar, wind, and energy storage systems, ensuring a stable and consistent renewable energy supply. According to the company’s filing, the project is expected to be completed within 24 months, contributing to NTPC’s commitment to increase its renewable energy footprint.

Investor Confidence Soars as Tata Power Climbs

The announcement of the deal had an immediate and favorable impact on Tata Power’s share prices. The company’s shares rose more than 4% intraday on the BSE, demonstrating robust investor confidence. The market reacted positively due to the size of the order and the increasing relevance of dispatchable renewable energy in balancing grid demand, a segment that’s becoming increasingly critical in India’s evolving energy infrastructure.

Strategic Importance of Dispatchable Renewables

What sets this deal apart is the emphasis on firm and dispatchable renewable energy—a category where energy generation can be controlled or scheduled based on demand. Unlike traditional solar or wind projects that depend on weather conditions, dispatchable renewables incorporate energy storage solutions such as batteries, providing power even when the wind isn’t blowing or the sun isn’t shining. This flexibility is vital in supporting grid stability and accelerating India’s transition to a more sustainable power mix.

Tata Power’s Expanding Renewable Portfolio

Tata Power, through TPREL, has been aggressively expanding its renewable portfolio, with operational capacity surpassing 4.1 GW and an additional 3.5 GW under implementation. This latest deal is a testament to its focus on integrated energy solutions combining solar, wind, and battery storage. Earlier this year, the company signed several agreements with state governments and private players, positioning itself as a frontrunner in India’s clean energy landscape.

NTPC’s Role in Powering Green Growth

NTPC, India’s largest energy conglomerate, has strategically pivoted toward renewable energy. With plans to install 60 GW of renewable capacity by 2032, the company has been actively partnering with private sector players to fulfil its clean energy agenda. This collaboration with Tata Power reflects NTPC’s strategy of creating reliable and environmentally sustainable energy assets, contributing to India’s energy security and net-zero ambitions.

Market Analysts Predict Further Upside

Following the announcement, several brokerage houses issued bullish outlooks on Tata Power, citing the large deal size, positive implications on revenue visibility, and strong execution capabilities. Analysts expect further re-rating of the stock as Tata Power continues to secure similar high-value contracts in the renewable space. Additionally, the deal could boost the company’s EBITDA margins, given the high-value nature of dispatchable renewable projects.

Looking Ahead: A Green Future for Tata Power

As India intensifies efforts to decarbonise its economy, companies like Tata Power are anticipated to play a crucial role in developing the future energy landscape. With robust technical expertise, scalable infrastructure, and a clear strategic direction, Tata Power capitalises on immediate opportunities and builds a long-term foundation for sustainable growth.
This Rs 4,500 crore order is more than just a commercial win—it symbolises India Inc.’s readiness to embrace innovation and sustainability in equal measure. As the world watches India’s green energy journey unfold, Tata Power stands tall as one of its strongest pillars.

 

 

 

 

 

 

The image added is for representation purposes only

Swiggy Launches ‘Pyng’ App to Address Unmet Demand for Professional Services